JPMED

Company Overview

Snapshot

Founded in February 1999 by Eitan Harduf and Doron Friedman, JPMED operates with 1–10 employees. The company holds a patent for its drug delivery systems, focusing on emulsion-based treatments.

Business overview

JPMED specializes in developing products for skin, ear, and mouth ailments, leveraging its proprietary oil-in-glycerin emulsion technology. This innovative drug delivery system allows for the dissolution of essential oils without harsh chemicals. The company's product portfolio includes Ear Comfort ear drops, Free Rinse mouthwash. JPMED operates within the Health Tech & Life Sciences sector, specifically targeting the pharmaceuticals market with its B2B business model.

Company Intelligence Q&A

What is JPMED's core technology?

JPMED's core technology is a patent-protected oil-in-glycerin emulsion system designed for dissolving essential oils without the need for alcohol, harsh chemicals, or synthetic solvents. This system forms the basis for its various therapeutic products.

What products has JPMED developed?

JPMED has developed several products, including Ear Comfort (steroid- and antibiotic-free ear drops), Free Rinse mouthwash, Aphta Gel (for canker sores), and Ora Protect (for mucositis). These products utilize the company's proprietary emulsion-based drug delivery system.

In which markets are JPMED's products available or being registered?

JPMED's products are registered for human use in Israel and are currently undergoing registration processes in Australia and New Zealand.

Who are the founders of JPMED?

JPMED was co-founded by Eitan Harduf and Doron Friedman.

When was JPMED founded?

JPMED was founded in February 1999.